Then, the relationship among OX40, OX40L, PD-1, PD-L1, CD3, CD4, CD8, FOXP3, tumor mutation burden (TMB), OS, recurrence-free survival (RFS), and other clinicopathological characteristics was fully explored. The gene discussed is PDCD1; the disease is neoplasm.